Pediatrics

According to researchers from University of Michigan and Duke University, children with Medicaid or other public insurance are far less likely than those with private insurance to have had a vision check in the last year at a primary care office.

The Vanderbilt University Medical Center study contradicts earlier studies from East Asia that showed the small dose of atropine is effective in slowing progression of myopia.

The month will be dedicated to educating families on the importance of healthy vision and early access to healthcare.

A study found the approach identifies high-risk patients so all preemies don’t need to undergo an invasive eye exam.

OCT methods are invaluable in the assessment of patients with the condition.

Experts weigh pros and cons of treatment option for orbital cellulitis in pediatric patients

Vitrectomy is a tool that can help surgeons curb complications.

The $150 Million Series B funding will allow for the registration and launch of gilderuretinol, the first and only medicine in clinical development to address the underlying mechanism of Stargardt disease.

NVK002 is a proprietary, investigational, preservative-free eye drop administered nightly and intended for patients ages 3 to 17.

The photochromic lenses, available in Singapore, provide added protection against intensive sunlight and can darken outdoors and fade back to transparent indoors.

The investigative team wanted to provide physicians with reference guidelines to aid in the prevention and control of myopia.

The number of cases continues to rise throughout the world

Nonpowder guns, like NERF guns, are causing an increase in ocular injuries in children.

Scientists at Medical College of Georgia demonstrated in their animal model of retinopathy of prematurity that the small molecule K604, which is being explored in cancer and Alzheimer’s, can block the development of leaky, obstructive blood vessels in the retina, tamp down inflammation and enable more normal blood vessel growth

Vitrectomy, lensectomy remain the primary surgical approaches for condition.

The UCL-Moorfields team have developed a deep learning AI model to screen for ROP, which was trained on a sample of 7,414 images of the eyes of 1,370 newborns who had been admitted to the Homerton Hospital, London, and assessed for ROP by ophthalmologists.

Glaucoma specialists nationwide reported that glaucoma-related adverse events were common after cataract surgery in children.

Pros and cons of anti-VEGF drugs and improved visualization of abnormalities in ROP.

The study compared eyes with retinopathy of prematurity (ROP) that were treated with laser and age-matched control eyes without ROP.

A study shows Atropine 0.01% eye drops decreased myopia progression in children over the course of 1 year.

According to National Eye Institute researchers, the strategy may speed the delivery of therapeutic options relative to time it would take to develop gene therapies.

The Phase 1/2 Clinical Trial is for the treatment of retinitis pigmentosa and Leber congenital amaurosis.

Hurdles include limited space, handling thin sclera, choosing the right site.

While low-dose atropine eye drops are currently being used to slow myopia progression in several countries in Asia, researchers set out to determine if the medication could also the onset of myopia.

During a presentation at the EnVision Summit Ophthalmology 2023 at El Conquistador Resort in Puerto Rico, Elena Bitrian, MD, outlines the challenges that surgeons are confronted with surgically in pediatric eyes, including the limited working space and palpebral fissure, axial length, and avoidance of the thin sclera and shallow scleral pass.

The approval of aflibercept for preterm infants with retinopathy of prematurity (ROP) expands the treatment armamentarium for these patients, comments Prof Anat Loewenstein.

According to Regeneron, aflibercept injection is now approved to treat five retinal conditions caused by ocular angiogenesis.

Wills Eye Hospital’s annual Give Kids Sight Day provides access to eyecare for children.

Jefferson Doyle, MBBCh, MD, PhD, MHS, of the Wilmer Eye Institute at Johns Hopkins University School of Medicine, addresses myopic concerns, such as public health measures including time outdoors, as well as pharmacological approaches including the current atropine data that has been completed and ongoing studies.

The company is poised to roll out its eye-tracking amblyopia treatment to the U.S. market.